Invesco Ltd. lifted its stake in Clarivate PLC (NYSE:CLVT - Free Report) by 102.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 788,362 shares of the company's stock after purchasing an additional 398,176 shares during the period. Invesco Ltd. owned approximately 0.12% of Clarivate worth $3,098,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in Clarivate by 7.6% in the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 40,253 shares of the company's stock valued at $158,000 after buying an additional 2,858 shares in the last quarter. Millstone Evans Group LLC lifted its position in shares of Clarivate by 156.6% during the 1st quarter. Millstone Evans Group LLC now owns 7,545 shares of the company's stock valued at $30,000 after acquiring an additional 4,605 shares during the period. Deutsche Bank AG boosted its stake in shares of Clarivate by 27.4% during the 4th quarter. Deutsche Bank AG now owns 26,217 shares of the company's stock worth $133,000 after acquiring an additional 5,641 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in shares of Clarivate by 34.9% during the 4th quarter. Tower Research Capital LLC TRC now owns 27,995 shares of the company's stock worth $142,000 after acquiring an additional 7,247 shares in the last quarter. Finally, Bessemer Group Inc. purchased a new position in Clarivate in the 1st quarter valued at approximately $30,000. 85.72% of the stock is currently owned by institutional investors and hedge funds.
Clarivate Stock Performance
Clarivate stock opened at $4.38 on Friday. The firm has a market capitalization of $2.94 billion, a P/E ratio of -7.06 and a beta of 1.40. Clarivate PLC has a 52 week low of $3.04 and a 52 week high of $7.15. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.90. The stock has a fifty day moving average price of $4.25 and a 200 day moving average price of $4.16.
Clarivate (NYSE:CLVT - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The company reported $0.18 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.18. Clarivate had a negative net margin of 17.33% and a positive return on equity of 8.65%. The company had revenue of $621.40 million during the quarter, compared to the consensus estimate of $587.17 million. During the same period in the previous year, the firm earned $0.20 earnings per share. Clarivate's revenue for the quarter was down 4.4% on a year-over-year basis. Clarivate has set its FY 2025 guidance at 0.600-0.700 EPS. Equities research analysts anticipate that Clarivate PLC will post 0.63 earnings per share for the current year.
Insider Activity
In other news, insider James Gordon Samson sold 100,000 shares of the company's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $4.53, for a total value of $453,000.00. Following the completion of the transaction, the insider directly owned 1,271,103 shares in the company, valued at approximately $5,758,096.59. This represents a 7.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 23.18% of the stock is owned by corporate insiders.
Analyst Ratings Changes
A number of research firms have commented on CLVT. Wall Street Zen downgraded Clarivate from a "buy" rating to a "hold" rating in a research report on Saturday, June 21st. Jefferies Financial Group started coverage on Clarivate in a research note on Friday, July 18th. They set a "hold" rating and a $4.50 price target for the company. Three analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Reduce" and an average price target of $4.83.
Check Out Our Latest Stock Report on Clarivate
About Clarivate
(
Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.